Susquehanna International Group, LLP Medicinova Inc Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$2.01 - $2.6 $9,245 - $11,960	-4,600 Reduced 30.07%	10,700 $22,000
Q2 2023 Aug 11, 2023	BUY	$2.09 - $2.43 $31,976 - $37,179	15,300 New	15,300 $35,000
Q4 2021 Feb 14, 2022	SELL	$2.61 - $4.42 $59,769 - $101,218	-22,900 Reduced 60.74%	14,800 $40,000
Q3 2021 Nov 15, 2021	BUY	$3.4 - $4.24 $48,280 - $60,208	14,200 Added 60.43%	37,700 $143,000
Q2 2021 Aug 11, 2021	SELL	$3.76 - $5.14 $68,808 - $94,062	-18,300 Reduced 43.78%	23,500 $100,000
Q1 2021 May 17, 2021	SELL	$4.81 - $8.74 $86,580 - $157,320	-18,000 Reduced 30.1%	41,800 $211,000
Q4 2020 Feb 16, 2021	BUY	$5.03 - $6.31 $300,794 - $377,338	59,800 New	59,800 $315,000
Q3 2018 Nov 14, 2018	SELL	$7.06 - $12.49 $72,718 - $128,647	-10,300 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$7.96 - $13.23 $81,988 - $136,269	10,300 New	10,300 $82,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $89.8M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.